A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)
Clinical trial NCT01571557 · COMPLETED
Trial details
- NCT number
- NCT01571557
- Sponsor
- Allergan
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2012-04-30
- Primary completion
- 2014-03-31
- Enrollment
- 573
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.